P. Irani

A look at clinical trial design for new antimicrobials for the adult population

M. Bassetti, D. Giacobbe, M. Peghin, 2019, Expert review of clinical pharmacology.

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

K. Kazmierczak, J. Karlowsky, D. Sahm, 2021, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program

Y. Carmeli, J. Mazuski, A. Torres, 2021, Infectious Diseases and Therapy.

VLDL-1 production involves 3 steps : 1 )

P. Irani, K. Madhu, J. Rawal, 2022 .

Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK)

N. Woodford, F. Davies, H. H. Wu, 2018, The Journal of antimicrobial chemotherapy.

European and Russian physician awareness of best management approaches for infections due to antibiotic-resistant Gram-negative bacteria

R. Epstein, M. Khalid, R. Aubert, 2017, Current medical research and opinion.

Cost-effectiveness Comparison of Ceftazidime/Avibactam Versus Meropenem in the Empirical Treatment of Hospital-acquired Pneumonia, Including Ventilator-associated Pneumonia, in Italy.

M. Bassetti, A. Torres, C. Charbonneau, 2020, Clinical therapeutics.

Hospital physician awareness about management of antibiotic-resistant gram-negative (ARGN) infections

R. Epstein, M. Khalid, J. Teagarden, 2015, Intensive Care Medicine Experimental.

Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review

Á. Soriano, Y. Carmeli, A. Omrani, 2021, Infectious Diseases and Therapy.

Atherogenic dyslipidemia

P. Irani, K. Madhu, C. Manjunath, 2013, Indian journal of endocrinology and metabolism.

Review of Ceftazidime-Avibactam for the Treatment of Infections Caused by Pseudomonas aeruginosa

G. Rossolini, G. Daikos, P. Irani, 2021, Antibiotics.

The Use and Effectiveness of Ceftazidime–Avibactam in Real-World Clinical Practice: EZTEAM Study

Á. Soriano, M. Bassetti, Marisa Sánchez, 2023, Infectious Diseases and Therapy.